In vitro and in vivo enzyme studies of polyhemoglobin-tyrosinase

Biotechnology and Bioengineering

Volumn 86, Issue 7, 2004, Pages 835-841

  Yu, B ^a   Chang, Thomas Ming Swi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Crosslinking; Melanoma; Polyhemoglobin; Polyhemoglobin tyrosinase; Tyrosine

Indexed keywords

CROSSLINKING; GROWTH KINETICS; HEMOGLOBIN; PATIENT TREATMENT; SOLUTIONS; TUMORS;

INTRAVENOUS INJECTION; POLYHEMOGLOBIN;

ENZYMES;

GLUTARALDEHYDE; HEMOGLOBIN DERIVATIVE; MONOPHENOL MONOOXYGENASE; POLYHEMOGLOBIN; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS LINKING; DIET RESTRICTION; DRUG STABILITY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA; MOLECULAR WEIGHT; NAUSEA; NONHUMAN; NORTH AMERICA; POLYMERIZATION; RAT; STRUCTURE ACTIVITY RELATION; VOMITING; WEIGHT REDUCTION;

ALDEHYDES; ANIMALS; BLOOD CIRCULATION TIME; CROSS-LINKING REAGENTS; ENZYME STABILITY; HEMOGLOBINS; INJECTIONS, INTRAVENOUS; MELANOMA; MONOPHENOL MONOOXYGENASE; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

ANIMALIA;

EID: 2942627440     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.20084     Document Type: Article

References (20)

1. Bhatnagar V, Srirangam A, Abburi R. 1998. In vitro modulation of proliferation and melanization of melanoma cells by citrate. Mol Cell Biochem 187:57-65.
2. Borden E. C. (Ed.) 2002. Melanoma: Biologically targeted therapeutics. New York: Humana Press.
3. Bunn HF. 1993. The use of hemoglobin as a blood substitute. Am J Hematol 42:112-117.
4. Chang TMS. (Ed.) 1993. Blood substitutes and oxygen carriers. New York: Marcel Dekker.
5. Chang TMS. 1997. Blood substitutes: Principles, methods, products and clinical trials, Vol. 1. Basel/New York: Karger Landes Systems.
6. Duckworth HW, Coleman JE. 1970. Physiochemical and kinetic properties of mushroom tyrosinase. J Biol Chem 245:1613-1625.
7. Frankenberger M, Hauck RW, Frankenberger B, Haussinger K, Maier KL, Heyder J, Ziegler-Heitbrock HW. 2001. All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9 (MMP-9) and upregulates tissue inhibitor of metalloproteinase-1 (TIMP-1) in human bronchoalveolar lavage cells. Mol Med 7:263-270.
8. Fu YM, Yu ZX, Pelayo BA, Ferrans VJ, Meadows GG. 1999. Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency. Cancer Res 59:758-765.
9. Hartmann RR, Rimoldi D, Lejeune FJ, Carrel S. 1997. Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells. Melanoma Res 7:S27-S33.
10. Jimbow K, Iwashina T, Alena F, Yamada K, Pankovich J, Umemura T. 1993. Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma. J Invest Dermatol 100:231S-238S.
11. Letellier S, Garnier JP, Spy J, Stoitchkov K, Bricon TL, Baccard M, Revol M, Kerneis Y, Bousquet B. 1999. Development of metastases in malignant melanoma is associated with an increase in the plasma. Melanoma Res 9:389-394.
12. Li Z, Hromchak R, Bloch A. 1997. Differential expression of proteins regulating cell cycle progression in growth vs. differentiation. Biochim Biophys Acta 1356:149-159.
13. Lotan R. 2003. Receptor-independent induction of apoptosis by synthetic retinoids. J Biol Regul Homeost Agents 17:13-28.
14. MacDonald SL, Pepper DS. 1994. Hemoglobin polymerization. Methods Enzymol 231:287-308.
15. Meadows GG, Pierson HF, Abdallah RM, Desai PR. 1982. Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbiodopa-levodopa methyl ester chemotherapy. Cancer Res 42:3056-3063.
16. Meadows GG, Oeser DE. 1983. Response of B16 melanoma-bearing mice to varying dietary levels of phenylalanine and tyrosine. Nutr Rep Int 28:1073-1082.
17. Potterf BS, Hearing VJ. 1998. Tyrosine transport into melanosomes is increased following stimulation of melanocyte differentiation. Biochem Biophys Res Commun 248:795-800.
18. Uhlenkott CE, Huijzer JC, Cardeiro DJ, Elstad CA, Meadows GG. 1996. Attachment, invasive, chemotaxis, and prteinase expression of B16-BL6 melanoma cells exhibiting a low metastatic phenotype after exposure to dietary restriction of tyrosine and phenylalanine. Clin Exp Metastasis 14:125-137.
19. Waalkes TP, Udenferiend S. 1957. A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med 11: 733-736.
20. Yu B, Chang TMS. 2004. In vitro and in vivo effects of polyhemoglobin-tyrosinase on murine B 16 F 10 melanoma. Melanoma Res (in press).